Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009–2017

Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

(2019) Jane Armitage et al.   LANCET

Sex Differences in the Use of Statins in Community Practice

(2019) Michael G. Nanna et al.  

Myocardial infarction and peripheral arterial disease: Treatment patterns and long-term outcome in men and women results from a Swedish nationwide study

(2019) B Sigvant et al.   European Journal of Preventive Cardiology

Statins in Peripheral Artery Disease

(2018) Aaron W. Aday et al.   CIRCULATION

Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011 to 2014

(2017) Robert S. Rosenson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Adherence to High-Intensity Statins Following a Myocardial Infarction Hospitalization Among Medicare Beneficiaries

(2017) Lisandro D. Colantonio et al.   JAMA Cardiology

Interpretation of the evidence for the efficacy and safety of statin therapy

(2016) Rory Collins et al.   LANCET

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

(2015)   LANCET

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

(2015) Christopher P. Cannon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Gender and racial disparities in adherence to statin therapy: A meta-analysis

(2013) Jennifer Lewey et al.   AMERICAN HEART JOURNAL

MPR AND PDC: IMPLICATIONS FOR INTERPRETATION OF ADHERENCE RESEARCH RESULTS

(2013) Z.A. Clancy   VALUE IN HEALTH

Missed Opportunities

(2012) Sumeet Subherwal et al.   CIRCULATION

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

Recent Nationwide Trends in Discharge Statin Treatment of Hospitalized Patients With Stroke

(2010) Bruce Ovbiagele et al.   STROKE

Persistent Use of Secondary Preventive Drugs Declines Rapidly During the First 2 Years After Stroke

(2010) Eva-Lotta Glader et al.   STROKE

Statin Treatment and the Occurrence of Hemorrhagic Stroke in Patients With a History of Cerebrovascular Disease

(2008) Mervyn D.I. Vergouwen et al.   STROKE